The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 23 Dec 2002
doi: 10.1242/jcs.00263
Research Article
Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells
Emma Marshman,
Kirsty A. Green,
David J. Flint,
Anne White,
Charles H. Streuli,
and
Melissa Westwood*
* Author for correspondence (e-mail: melissa.westwood{at}man.ac.uk)
Insulin-like growth factors (IGFs) are important survival signals that can protect a range of cell types from apoptosis. Although IGF bioavailability is modulated by high affinity interactions with IGF-binding proteins (IGFBPs), there is currently no experimental evidence that IGFBPs regulate the survival function of IGFs in the mammary gland. We have examined IGFBP expression during mammary gland development and studied the effects of IGFBPs on IGF-mediated survival and signalling in mammary epithelial cells in culture. IGFBP-5 protein was greatly increased during days 1-3 of mammary gland involution, when levels of apoptosis are dramatically elevated to remodel the gland after lactation. Primary cultures of mammary epithelial cells (MECs) expressed IGFBP-5 from their basal surface suggesting that IGFBP-5 is suitably located to inhibit IGF signalling. Addition of exogenous IGFBP-5 and IGFBP-3 to MECs suppressed IGF-I-mediated survival, resulting in threefold greater apoptosis in cells incubated with IGF-I and IGFBP-5 compared with IGF-I alone. Examination of signalling pathways involved in apoptosis revealed that phosphorylation of PKB and the forkhead transcription factor, FKHRL1, was induced by IGFs, but that phosphorylation was blocked by IGFBP-5 and IGFBP-3. This study provides evidence that IGFBP-5 plays an important role in the regulation of apoptosis in the mammary gland.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Tripathi, D. A. M. Salih, A. C. Drozd, R. A. Cosgrove, L. J. Cobb, and J. M. Pell
IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo
FASEB J,
August 1, 2009;
23(8):
2616 - 2626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Annen, C. M. Stiening, B. A. Crooker, A. C. Fitzgerald, and R. J. Collier
Effect of continuous milking and prostaglandin E2 on milk production and mammary epithelial cell turnover, ultrastructure, and gene expression
J Anim Sci,
May 1, 2008;
86(5):
1132 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Kim, Y. B. Seu, S.-H. Baek, M. J. Kim, K. J. Kim, J. H. Kim, and J.-R. Kim
Induction of Cellular Senescence by Insulin-like Growth Factor Binding Protein-5 through a p53-dependent Mechanism
Mol. Biol. Cell,
November 1, 2007;
18(11):
4543 - 4552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Graham, D. M. Kilby, S. M. Firth, P. J. Robinson, and R. C. Baxter
The in Vivo Phosphorylation and Glycosylation of Human Insulin-like Growth Factor-binding Protein-5
Mol. Cell. Proteomics,
August 1, 2007;
6(8):
1392 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Blakely, A. J. Stoddard, G. K. Belka, K. D. Dugan, K. L. Notarfrancesco, S. E. Moody, C. M. D'Cruz, and L. A. Chodosh
Hormone-Induced Protection against Mammary Tumorigenesis Is Conserved in Multiple Rat Strains and Identifies a Core Gene Expression Signature Induced by Pregnancy.
Cancer Res.,
June 15, 2006;
66(12):
6421 - 6431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D J Flint, M Boutinaud, C B A Whitelaw, G J Allan, and A F Kolb
Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.
J. Mol. Endocrinol.,
June 1, 2006;
36(3):
435 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Sorrell, J. H. Shand, E. Tonner, M. Gamberoni, P. A. Accorsi, J. Beattie, G. J. Allan, and D. J. Flint
Insulin-like Growth Factor-binding Protein-5 Activates Plasminogen by Interaction with Tissue Plasminogen Activator, Independently of Its Ability to Bind to Plasminogen Activator Inhibitor-1, Insulin-like Growth Factor-I, or Heparin
J. Biol. Chem.,
April 21, 2006;
281(16):
10883 - 10889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thangaraju, M. Rudelius, B. Bierie, M. Raffeld, S. Sharan, L. Hennighausen, A-M. Huang, and E. Sterneck
C/EBP{delta} is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
Development,
November 1, 2005;
132(21):
4675 - 4685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yin, Q. Xu, and C. Duan
Paradoxical Actions of Endogenous and Exogenous Insulin-like Growth Factor-binding Protein-5 Revealed by RNA Interference Analysis
J. Biol. Chem.,
July 30, 2004;
279(31):
32660 - 32666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Green, M. J. Naylor, E. T. Lowe, P. Wang, E. Marshman, and C. H. Streuli
Caspase-mediated Cleavage of Insulin Receptor Substrate
J. Biol. Chem.,
June 11, 2004;
279(24):
25149 - 25156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Allar and T. L. Wood
Expression of the Insulin-Like Growth Factor Binding Proteins during Postnatal Development of the Murine Mammary Gland
Endocrinology,
May 1, 2004;
145(5):
2467 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function
J. Cell Sci.,
May 1, 2004;
117(9):
1737 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Diarra-Mehrpour, S. Arrabal, A. Jalil, X. Pinson, C. Gaudin, G. Pietu, A. Pitaval, H. Ripoche, M. Eloit, D. Dormont, et al.
Prion Protein Prevents Human Breast Carcinoma Cell Line from Tumor Necrosis Factor {alpha}-Induced Cell Death
Cancer Res.,
January 15, 2004;
64(2):
719 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jager, U. Werling, S. Rimpf, A. Jacob, and H. Schorle
Transcription Factor AP-2{gamma} Stimulates Proliferation and Apoptosis and Impairs Differentiation in a Transgenic Model
Mol. Cancer Res.,
October 1, 2003;
1(12):
921 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2002